-
Fury hits out at 'coward' Joshua as 'Battle of Britain' talks go on
-
Dolly Parton to get new Hollywood star after vandalism
-
Maltese tycoon acquitted of masterminding reporter's murder
-
Trump 'happy' Prince Harry and Meghan have left US
-
George Clooney: a Hollywood icon and campaigner
-
Michelson shocks Nakashima in US Open clash of rising Americans
-
Europe, US closer than they look on tech rules, says EU tech chief
-
Another body recovered after ferry capsizes off northern Cyprus: official
-
Clooney honoured as Hollywood-light Venice Film Festival kicks off
-
Cupertino Chamber President Claudio Bono Invited to White House with GiveaRoof 3-Year Plan to End Homelessness
-
Third-ranked Pegula, Medvedev power into US Open third round
-
Trump floats renaming Strait of Hormuz as 'Trump Strait'
-
Davis-Woodhall a doubt for Ultimate Championship after car crash
-
Man City, Chelsea fuel record-breaking Premier League transfer window
-
Third-ranked Pegula powers into US Open third round
-
Balogun rejected Everton move over transfer 'treatment'
-
Uber says laying off 'about 10%' of workforce worldwide
-
Northampton seek 'happy medium' in bid to keep England star Pollock
-
US judge rejects bid to break up Google's ad business
-
US energy secretary in Venezuela to sign Trump's 'biggest' oil deal
-
Rupert Murdoch 'very happy' to be played by Guy Pearce in new film
-
Branagh takes on action role in Apple's Cold War comedy 'Mayday'
-
Wall Street stocks rise despite bond yields, oil rising
-
Lawson fills in again for injured Hadjar at Monza
-
Brennan claims third Vuelta victory in stage 11 sprint
-
England omit Carse from squad for third Test against Pakistan
-
Nepal flood survivors cling to zipline to cross treacherous river
-
Venice festival gets underway with Clooney taking swipe at US government
-
US Treasury issues $1 coin with Trump's face on it
-
DNA tests and funerals in Nepal, a week after deadly floods
-
Fernandez 'didn't hesitate' over record Man City move
-
Iran threatens tougher strategy after US strikes kill 4 at wedding
-
Dutch shift 86 tonnes of gold from US, Canada to UK
-
Chevron unveils deal to double Venezuela venture output in 5 years
-
Nepal floods should mobilise climate action: UN green fund chief
-
Uganda names its oil 'Pearl Sweet' as it prepares for first exports
-
Nvidia boss presses G20 ministers to build AI infrastructure
-
Tiger Woods driver's license suspended for five years after crash
-
Liminal Launches Liminal Prime for Institutional OTC and Stablecoin Liquidity
-
Germany probes latest sabotage attacks on power grid
-
10 missing as cargo ship sinks after collision off Istanbul
-
Wall Street stocks mixed as energy prices, bond yields turn lower
-
30 years on, 'Tomb Raider' reboot sees Lara Croft through a 'modern lens'
-
Tiger Woods pleads guilty to reckless driving, license suspended
-
King Charles, Macron to view Bayeux Tapestry as French leader starts UK visit
-
Missing passengers likely went down with sunken ferry: N.Cyprus official
-
George Clooney says US run by 'least qualified people'
-
Premier League clubs splash cash to smash transfer record
-
China's Xi urges against Mideast interference in rare Egypt visit
-
Melting glaciers an 'immediate' climate risk: author of UN report
Featured
Last news
Mosaic Announces First Quarter 2025 Earnings Results Dates
TAMPA, FL / ACCESS Newswire / April 16, 2025 / The Mosaic Company (NYSE:MOS) plans to release first quarter 2025 earnings results on Tuesday, May 6th, after close of trading on the New York Stock Exchange. The company will issue a news wire alert when earnings materials are publicly available on the company's website.
Protagonist Therapeutics Reports Granting of Inducement Award
NEWARK, CA / ACCESS Newswire / April 16, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that on April 15, 2025 (the "Grant Date"), it issued an equity inducement award to a new employee upon his commencement of employment with the Company in accordance with the terms of his employment offer letter. The award was granted under the Company's Amended and Restated 2018 Inducement Plan, which was adopted on May 29, 2018, and amended on February 18, 2020 and February 15, 2022.
New to The Street Renews Acurx Pharmaceuticals (NASDAQ: ACXP) for Exclusive 6-Month Media Series Including Nationwide TV, Earned Media, and Expanded Digital Reach
NEW YORK CITY, NEW YORK / ACCESS Newswire / April 16, 2025 / New to The Street, a premier business television and media platform, is proud to announce the renewal of its media partnership with Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) for a new 6-month strategic campaign. The series will include long-form interviews airing as sponsored programming on Fox Business and Bloomberg Television, earned media placements, over 50 national commercials per month, and expanded visibility across New to The Street's 2.4M+ subscriber YouTube channel and digital networks.
Alkaline Water Company Announces National Distribution Agreement with Major Wholesale Grocery Distributor
Partnership Expands Alkaline88's Footprint Across Key U.S. Regions, Fueling Market Penetration
Think Power Solutions Renews Contract with AEP, Expanding AI-Enabled Utility Services with Industry-Leading Safety Record
PLANO, TX / ACCESS Newswire / April 16, 2025 / Think Power Solutions, a leading AI-enabled utility infrastructure solutions provider with an industry-leading safety record, is proud to announce the renewal of its contract with American Electric Power (AEP), one of the nation's largest electric utility companies. This agreement reinforces Think Power Solutions' commitment to delivering innovative infrastructure solutions and expert consultancy services to support AEP's transmission and construction initiatives.
Phase 1 Equity Welcomes Respected Texas Orthodontic Practice
Strengthening a Doctor-Led Network Rooted in Clinical Excellence and Shared Values
SOHM, Inc. Announces Patent Allowance/Approval in South Korea
CHINO HILLS, CA / ACCESS Newswire / April 16, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in Gene Editing and Cell Engineering is pleased to announce that it has received a Notice of Allowance/Approval from the South Korea Patent Office for its innovative technology entitled "CAS 9 RETROVIRAL INTEGRASE AND CAS 9 RECOMBINASE SYSTEMS FOR TARGETED INCORPORATION OF A DNA SEQUENCE INTO A GENOME OF A CELL OR ORGANISM." Korea Patent Application No. 10-27695915
LQR House Announces 35-for-1 Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
MIAMI BEACH, FLORIDA / ACCESS Newswire / April 16, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, announces that its Board of Directors and Chief Executive Officer have approved a proposed reverse stock split of its common stock at a ratio of 35-for-1. The reverse stock split will become effective on April 21, 2025, at 12:01 a.m., Eastern Time. The Company's common stock will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the existing symbol "YHC" and will begin trading on a split-adjusted basis when the market opens on April 21, 2024. The new CUSIP number for the common stock following the reverse stock split will be 50215C307.
MIRA Pharmaceuticals Announces Positive Results for Ketamir-2 in Diabetic Neuropathy Animal Model, Reinforcing Confidence Ahead of Phase I Completion
Ketamir-2 Demonstrates Strong Efficacy in Diabetic Neuropathy Model, with Some Subjects Achieving Complete Symptom Reversal
Regenerative Medical Technologies Group Increased 2024 Sales by 70% Year Over Year with Increased Q4 Sales by 146% Year Over Year and Achieved Positive Operating Income for 2024
RMTG Reports Huge Sales Increases and Continued Positive Operating Income
Beyond Creatinine: First Real-World Evidence Highlights Proenkephalin A 119–159 (penKid) as a Valuable Kidney Function Biomarker
Real-World Implementation: Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in intensive care unit (ICU), demonstrating its effectiveness in assessing kidney function and predicting acute kidney injury (AKI) in over 4,000 patients.Superior Dynamics: PenKid augments traditional markers by detecting rapid changes in kidney function, particularly beneficial in critically ill patients where timely information is crucial.Clinical Impact: PenKid proved valuable in identifying high-risk patients at ICU admission, especially those with a normal serum creatinine. Additionally, penKid provided valuable insights into kidney function during renal replacement therapy (RRT).International Recognition: Beyond its use in reference hospitals in Germany, international experts, including those at the Mayo Clinic, acknowledge the added value of penKid on top of standard care.
Supplement Manufacturing Partner, Inc. Issues Recall on Dorado Nutrition Brand Spermidine Supplement 10mg Vegetable Capsules (Spermidine 3HCL) Due To Undeclared Wheat Allergen
LARGO, FL / ACCESS Newswire / April 16, 2025 / Supplement Manufacturing Partners, Inc. is recalling Dorado Nutrition brand Spermidine Maximum Strength 10 MG per serving, because it contains undeclared wheat. People who have an allergy or severe sensitivity to wheat run the risk of serious or life-threatening allergic reaction if they consume this product.
Maradona's daughter says doctors could have prevented his death
Argentine football legend Diego Maradona's daughter told a court Tuesday his death "would have been avoided" if doctors caring for him after surgery had done their jobs.
Family seeks homicide charges against owners of collapsed Dominican nightclub
The family of one of 231 people killed when a Dominican nightclub roof collapsed on concert-goers is seeking manslaughter charges against the establishment's owners, according to a legal filing Tuesday.
Facebook added 'value' to Instagram, Zuckerberg says in antitrust trial
Social media titan Mark Zuckerberg testified for a second day Tuesday in a landmark US antitrust trial, defending his conglomerate Meta against accusations it took over Instagram and WhatsApp to devour budding competitors.
Peru court sentences ex-president Humala to 15 years for graft
A Peruvian court on Tuesday sentenced ex-president Ollanta Humala and his wife to 15 years in prison for graft linked to a globe-spanning corruption scandal involving Brazilian construction group Odebrecht paying bribes to politicians.
French prisons hit by mystery arson and gunfire attacks
A wave of coordinated attacks have hit prisons across France, with unknown assailants torching cars outside several jails, leaving mysterious inscriptions and hitting one facility with automatic gunfire.
Ecuador electoral council rejects claims of fraud in presidential vote
Ecuador's CNE electoral council on Tuesday dismissed claims of fraud in presidential elections that saw incumbent Daniel Noboa emerge victorious over leftist rival Luisa Gonzalez.
'Unprecedented' Europe raids net 200 arrests, drugs haul
Police in Europe staged "unprecedented" raids against four organised crime groups on Tuesday, arresting more than 200 people across five countries, primarily in Turkey, in a "massive blow" against drug-trafficking networks.
Andrew Tate accusers suing for 'six-figure' sum, UK court hears
Four women suing the social media influencer Andrew Tate over abuse and coercive behaviour claims are seeking damages of more than 100,000 pounds ($132,000), London's High Court heard Tuesday.
Ukraine's Sumy prepares to bury victims of 'bloody Sunday'
Standing on the doorstep of a funeral home on Tuesday, Lyudmyla Mosunova felt helpless while thinking about the burial of her mother Tetyana, killed in a Russian missile attack two days before.
French prisons targeted with arson, gunfire: ministry
Cars have been set on fire near several prisons in France while one was targeted with automatic gunfire, in possible retaliation against government anti-drug policies, justice ministry officials said on Tuesday.
Employee dead, client critical after Paris cryotherapy session goes wrong
A cryotherapy session in Paris has turned deadly with one woman dying and another hospitalised in critical condition due to a nitrogen leak from a cold chamber, according to French investigators.
China accuses US spies of Asian Winter Games cyberattacks
Chinese security officials said Tuesday they had implicated three US "secret agents" in cyberattacks during February's Asian Winter Games in the northeastern city of Harbin, offering a reward for information on the alleged spies.
Harvey Weinstein New York retrial for sex crimes to begin
Disgraced Hollywood mogul Harvey Weinstein faces a retrial starting Tuesday, on rape and sex assault charges for which a previous verdict was overturned, forcing survivors who helped fire up the "MeToo" movement to testify against him once again.
US grounds helicopter company behind fatal New York tour
US regulators on Monday issued an emergency order grounding the helicopter tour company behind last week's deadly crash in New York.
NHI Announces First Quarter 2025 Earnings Release and Conference Call Dates
MURFREESBORO, TN / ACCESS Newswire / April 15, 2025 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2025. NHI plans to issue its earnings release after the market closes on Monday, May 5, 2025, and will host a conference call on the following day, Tuesday, May 6, 2025, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the access code 111859.
Buddy Bench Brings Community, Compassion, and Connection to Every Park, School, and Playground
Coated Outdoor Furniture Launches American-Made Outdoor Benches Designed to Promote Inclusion, Support Mental Health, and Create Meaningful Connections Among Children
Arthritis Foundation Launches Green Heart Fridays: A Nationwide Free Art Activation for Arthritis Awareness Month
ATLANTA, GA / ACCESS Newswire / April 15, 2025 / May is Arthritis Awareness Month, and the Arthritis Foundation, the number one resource for arthritis resources and information, is introducing Green Heart Fridays. This nationwide free art activation is aimed at uniting and inspiring the arthritis community while raising awareness of arthritis, the nation's #1 cause of disability. Central to the campaign is the Green Heart - a powerful symbol of support, resilience and connection for the millions of people living with arthritis.
CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS
CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and investment management firm based in Bogotá, Colombia for a proposed USD 5,000,000 (five million US dollars) equity loan to support the production and commercialization of CS Diagnostic Corp.'s assets and strategic developments.
Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
The statistically significant responder analysis results for Mytesi® (crofelemer) in the Phase 3 OnTarget study's prespecified subgroup of patients with breast cancer were the subject of a December 2024 poster presentation at the San Antonio Breast Cancer SymposiumLate-breaker abstract accepted by MASCC shows additional significant results for breast cancer subgroupJaguar planning to meet with FDA in Q2 2025 to discuss possible pathways for crofelemer approval for prophylaxis of diarrhea in patients with breast cancerA second late-breaker abstract, related to the results of a screening survey of cancer patients about oral mucositis and a follow-up focus group, has also been accepted for presentation at MASCC's 2025 Annual Meeting
Introducing Ownia Collection: A New Era of Guilt-Free Luxury Travel
Redefining Sustainable Luxury with a Curated Global Portfolio of Eco-Conscious Hotels